Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)
China flag China · Delayed Price · Currency is CNY
185.77
-2.23 (-1.19%)
At close: Feb 13, 2026

SHE:300760 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
32,97336,62434,87530,35425,25820,981
Other Revenue
101.68101.6856.6111.8311.7344.89
33,07536,72634,93230,36625,27021,026
Revenue Growth (YoY)
-10.88%5.13%15.04%20.17%20.18%27.00%
Cost of Revenue
13,23713,76712,76810,9568,9677,459
Gross Profit
19,83722,95922,16419,41016,30313,566
Selling, General & Admin
6,8816,8836,5346,1225,1054,509
Research & Development
3,5083,6663,4332,9232,5241,869
Other Operating Expenses
-52.29-261.66-308.79-80.36-83.14-100.81
Operating Expenses
10,60410,5869,9039,0017,5396,307
Operating Income
9,23412,37312,26110,4098,7647,259
Interest Expense
-21.97-19.41-13-10.69-8.63-
Interest & Investment Income
597.85626.87821.64357.91408.14385.7
Earnings From Equity Investments
------4.47
Currency Exchange Gain (Loss)
-51.28-51.28119.17171.96-227.66-253.4
Other Non Operating Income (Expenses)
100.88-87.45-72.51-67.82-85.92-70.86
EBT Excluding Unusual Items
9,85912,84213,11710,8608,8507,316
Gain (Loss) on Sale of Investments
-16.89109.3369.56-26.449.88-
Gain (Loss) on Sale of Assets
6.24.242.466.164.07-2.07
Asset Writedown
-43.78-1.75-274.92-0.74-7.47-16.87
Legal Settlements
-14.25-14.25-12.65-3.3-5.7-2.45
Other Unusual Items
80.2580.25109.68117.5166.78143.74
Pretax Income
9,87113,02013,01110,9549,0177,438
Income Tax Expense
1,0201,2801,4331,3431,013778.84
Earnings From Continuing Operations
8,85111,74011,5789,6118,0046,660
Minority Interest in Earnings
-249.75-71.483.81-3.54-2.49-1.93
Net Income
8,60111,66811,5829,6078,0026,658
Net Income to Common
8,60111,66811,5829,6078,0026,658
Net Income Growth
-30.55%0.74%20.56%20.07%20.18%42.24%
Shares Outstanding (Basic)
1,2111,2111,2121,2101,2151,216
Shares Outstanding (Diluted)
1,2111,2111,2121,2101,2151,216
Shares Change (YoY)
-0.09%-0.04%0.11%-0.36%-0.07%-
EPS (Basic)
7.109.649.567.946.595.48
EPS (Diluted)
7.109.639.567.946.595.48
EPS Growth
-30.49%0.79%20.42%20.50%20.28%42.24%
Free Cash Flow
6,56310,4738,37310,2267,5967,687
Free Cash Flow Per Share
5.428.656.918.456.256.32
Dividend Per Share
4.6306.2705.8004.5003.5002.500
Dividend Growth
-35.78%8.10%28.89%28.57%40.00%66.67%
Gross Margin
59.98%62.51%63.45%63.92%64.52%64.52%
Operating Margin
27.92%33.69%35.10%34.28%34.68%34.52%
Profit Margin
26.01%31.77%33.16%31.64%31.66%31.66%
Free Cash Flow Margin
19.84%28.52%23.97%33.67%30.06%36.56%
EBITDA
10,86213,68713,15811,1889,3807,731
EBITDA Margin
32.84%37.27%37.67%36.84%37.12%36.77%
D&A For EBITDA
1,6281,314896.04779.11616.47472.12
EBIT
9,23412,37312,26110,4098,7647,259
EBIT Margin
27.92%33.69%35.10%34.28%34.68%34.52%
Effective Tax Rate
10.33%9.83%11.01%12.26%11.24%10.47%
Revenue as Reported
33,07536,72634,93230,36625,270-
Advertising Expenses
-332.39359.41288.69223.68243.39
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.